Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
about
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesMetronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinomaNeuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upGastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsChemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.Therapy for metastatic pancreatic neuroendocrine tumors.Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathwayNANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasGuidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)A multimodal approach to the management of neuroendocrine tumour liver metastasesPharmacotherapy of Zollinger-Ellison syndrome.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesEvolving diagnostic and treatment strategies for pancreatic neuroendocrine tumorsContemporary management of nonfunctioning pancreatic neuroendocrine tumors.Non-functional pancreatic neuroendocrine tumor as an incidentaloma--a case report and review of literature.Zollinger-Ellison syndrome: recent advances and controversies.Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.
P2860
Q24603675-37D78206-6068-411C-B28B-1C65D5B14588Q26753070-A7CA95D6-88CA-4BE0-9262-C1C28B37BFBBQ28285545-E373EEBF-9D7E-4538-8FB4-64626C8532C9Q28290833-72572DB1-6858-4E36-BD95-DAE71E5C970EQ33783119-61E3F8CD-26D3-4378-AC03-7EDF872C04AEQ34357869-99E84261-6554-41A7-BE55-4348121A1922Q34887795-306FD10F-EA23-4A70-B1EE-5E5E3E01491EQ35001777-6BE4AA9B-F796-439E-A760-BA38F0F8F179Q35760798-3AABE32A-9A4E-42A8-9050-4C6E955506A0Q35810562-7B4852D1-A480-4B21-A164-BA873BCA3127Q36632665-CDED6947-1517-4636-AF97-11AB8F08123BQ37125550-F329FF37-F501-47C9-8CB5-2987ABEBCB3EQ37889407-907379A6-C163-47E8-9D57-6D5E6F5E6B54Q37947138-B4532BB0-4E12-47A3-BFD1-E19C69244EE7Q38052101-13C5ED85-01E5-44A6-834A-9AD85CE62A59Q38150165-6EC48658-C86B-4E9A-9787-622C2327E098Q38262113-BC6D6C13-C83B-465E-9DEC-E6D807B23903
P2860
Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
@ast
Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
@en
type
label
Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
@ast
Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
@en
prefLabel
Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
@ast
Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
@en
P2093
P1476
Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
@en
P2093
Christos Toumpanakis
Martyn E Caplin
P304
P356
10.1016/J.BEEM.2007.01.005
P577
2007-03-01T00:00:00Z